Proteomics Changes Associated with Resistance to Chemotherapy

Wang et al. (2015) used two similar breast cancer cell lines to investigate the proteomic changes associated with, and potentially responsible for, resistance to chemotherapy. By investigating the differences at the translational level, the research team sought to characterize pathways that might present new insights of potential therapeutic importance in this disease. Adriamycin is an anthracycline Read the rest of this article

The post Proteomics Changes Associated with Resistance to Chemotherapy appeared first on Accelerating Science.

from http://ift.tt/1JcGzLN
via IFTTT

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s